ES2646737T3 - Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico - Google Patents
Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico Download PDFInfo
- Publication number
- ES2646737T3 ES2646737T3 ES12750597.2T ES12750597T ES2646737T3 ES 2646737 T3 ES2646737 T3 ES 2646737T3 ES 12750597 T ES12750597 T ES 12750597T ES 2646737 T3 ES2646737 T3 ES 2646737T3
- Authority
- ES
- Spain
- Prior art keywords
- acid hydrochloride
- therapeutic system
- transdermal therapeutic
- aminolevulinic acid
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229950010481 5-aminolevulinic acid hydrochloride Drugs 0.000 title abstract 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 229920000058 polyacrylate Polymers 0.000 abstract 2
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 229920005601 base polymer Polymers 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000011241 protective layer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Sistema terapéutico transdérmico que comprende una capa de respaldo que es impermeable al principio activo, una matriz polimérica y una capa protectora desprendible caracterizado porque el principio activo es clorhidrato de ácido 5-aminolevulínico, porque el polímero de base de la matriz polimérica es un poliacrilato adhesivo y porque el poliacrilato ha sido obtenido sin agente de reticulación.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102011111865 | 2011-08-31 | ||
DE102011111865A DE102011111865A1 (de) | 2011-08-31 | 2011-08-31 | Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid |
PCT/EP2012/066541 WO2013030129A1 (de) | 2011-08-31 | 2012-08-24 | Transdermales therapeutisches system für 5-aminolävulinsäurehydrochlorid |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2646737T3 true ES2646737T3 (es) | 2017-12-15 |
Family
ID=46724447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES12750597.2T Active ES2646737T3 (es) | 2011-08-31 | 2012-08-24 | Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico |
Country Status (17)
Country | Link |
---|---|
US (2) | US10307382B2 (es) |
EP (1) | EP2750673B1 (es) |
JP (2) | JP6035335B2 (es) |
KR (1) | KR101933610B1 (es) |
CN (1) | CN103764135B (es) |
AU (1) | AU2012301042B2 (es) |
BR (1) | BR112014004635B1 (es) |
CA (1) | CA2844288C (es) |
DE (1) | DE102011111865A1 (es) |
DK (1) | DK2750673T3 (es) |
ES (1) | ES2646737T3 (es) |
MX (1) | MX351514B (es) |
NO (1) | NO2750673T3 (es) |
PL (1) | PL2750673T3 (es) |
PT (1) | PT2750673T (es) |
RU (1) | RU2607657C2 (es) |
WO (1) | WO2013030129A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9179844B2 (en) | 2011-11-28 | 2015-11-10 | Aranz Healthcare Limited | Handheld skin measuring or monitoring device |
CZ307444B6 (cs) * | 2015-04-22 | 2018-08-29 | Jakub Rak | Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů |
US10013527B2 (en) | 2016-05-02 | 2018-07-03 | Aranz Healthcare Limited | Automatically assessing an anatomical surface feature and securely managing information related to the same |
US11116407B2 (en) | 2016-11-17 | 2021-09-14 | Aranz Healthcare Limited | Anatomical surface assessment methods, devices and systems |
US11903723B2 (en) | 2017-04-04 | 2024-02-20 | Aranz Healthcare Limited | Anatomical surface assessment methods, devices and systems |
KR102171200B1 (ko) | 2018-11-20 | 2020-10-28 | 제너럴바이오(주) | 5-아미노레불린산 수화염화물과 그 유도체를 유효성분으로 함유하는 여드름성 피부염 개선 또는 그의 조성물 |
CN111517973B (zh) * | 2019-02-02 | 2023-08-04 | 中国科学院天津工业生物技术研究所 | 一种从发酵液中制备5-氨基乙酰丙酸盐酸盐的生产工艺及其应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996006602A1 (en) | 1993-08-27 | 1996-03-07 | Noven Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF |
HU0200901D0 (es) * | 1996-06-20 | 2002-08-28 | Lavipharm Sa | |
GR1002807B (el) | 1996-06-20 | 1997-11-13 | Lavipharm A.E. | Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του |
US5856566A (en) * | 1997-09-02 | 1999-01-05 | Dusa Pharmaceuticals, Inc. | Sterilized 5-aminolevulinic acid |
DE60017831T3 (de) * | 1999-01-14 | 2009-12-17 | Noven Pharmaceuticals, Inc., Miami | Dermale zusammensetzungen |
DE10034673C1 (de) * | 2000-07-17 | 2002-04-25 | Medac Klinische Spezialpraep | Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung |
CA2422865C (en) | 2000-08-16 | 2012-10-16 | The General Hospital Corporation D/B/A Massachusetts General Hospital | Aminolevulinic acid photodynamic therapy for treating sebaceous gland disorders |
KR100846912B1 (ko) | 2001-01-12 | 2008-07-17 | 페데랄노에고수다르스트벤노에유니타르노에프레드프리야티에고수다르스트벤니나우쉬니티센트르나우쉬노이슬레도바텔스키인스티튜트오르가니쉐스키크흐포루프로두크토브아이크르아시텔에이에프지업지엔트스니오피크 | 광에너지 요법 및 그 요법을 수행하기 위한 도포기 |
JP4394444B2 (ja) * | 2001-10-24 | 2010-01-06 | パワー ペーパー リミティド | 活性物質の制御された皮膚内デリバリーのためのデバイス及び方法 |
DE10200578A1 (de) | 2002-01-09 | 2003-07-10 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme |
DE10202487A1 (de) | 2002-01-23 | 2003-07-31 | Photonamic Gmbh & Co Kg | Dermales Applikationssystem für Aminolävulinsäure-Derivate |
DE10344334A1 (de) | 2003-09-24 | 2005-04-28 | Johann Berger | Gewebtes Gurtband |
EP1847264B1 (en) | 2005-01-31 | 2017-05-03 | Hisamitsu Pharmaceutical Co., Inc. | Bisoprolol patch |
US20060182790A1 (en) * | 2005-02-17 | 2006-08-17 | Flor Mayoral | Dermal medicaments application enhancer |
US20100087768A1 (en) * | 2008-10-02 | 2010-04-08 | Forlano Paula | Transdermal drug delivery system for liquid active ingredient |
-
2011
- 2011-08-31 DE DE102011111865A patent/DE102011111865A1/de not_active Ceased
-
2012
- 2012-08-24 NO NO12750597A patent/NO2750673T3/no unknown
- 2012-08-24 PL PL12750597T patent/PL2750673T3/pl unknown
- 2012-08-24 CN CN201280041826.1A patent/CN103764135B/zh active Active
- 2012-08-24 EP EP12750597.2A patent/EP2750673B1/de active Active
- 2012-08-24 WO PCT/EP2012/066541 patent/WO2013030129A1/de active Application Filing
- 2012-08-24 CA CA2844288A patent/CA2844288C/en active Active
- 2012-08-24 JP JP2014527607A patent/JP6035335B2/ja active Active
- 2012-08-24 ES ES12750597.2T patent/ES2646737T3/es active Active
- 2012-08-24 DK DK12750597.2T patent/DK2750673T3/da active
- 2012-08-24 RU RU2014111255A patent/RU2607657C2/ru active
- 2012-08-24 AU AU2012301042A patent/AU2012301042B2/en active Active
- 2012-08-24 KR KR1020147008255A patent/KR101933610B1/ko active IP Right Grant
- 2012-08-24 MX MX2014002215A patent/MX351514B/es active IP Right Grant
- 2012-08-24 PT PT127505972T patent/PT2750673T/pt unknown
- 2012-08-24 US US14/240,810 patent/US10307382B2/en active Active
- 2012-08-24 BR BR112014004635-2A patent/BR112014004635B1/pt active IP Right Grant
-
2016
- 2016-10-28 JP JP2016211246A patent/JP6203364B2/ja active Active
-
2019
- 2019-04-18 US US16/388,364 patent/US20190240166A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2750673A1 (de) | 2014-07-09 |
DE102011111865A1 (de) | 2013-02-28 |
KR20140056370A (ko) | 2014-05-09 |
WO2013030129A1 (de) | 2013-03-07 |
EP2750673B1 (de) | 2017-08-09 |
US20190240166A1 (en) | 2019-08-08 |
US10307382B2 (en) | 2019-06-04 |
CN103764135B (zh) | 2018-06-22 |
MX2014002215A (es) | 2014-04-30 |
CA2844288C (en) | 2019-08-20 |
MX351514B (es) | 2017-10-17 |
JP2014527537A (ja) | 2014-10-16 |
AU2012301042A1 (en) | 2014-03-20 |
AU2012301042B2 (en) | 2017-07-13 |
US20140323994A1 (en) | 2014-10-30 |
CN103764135A (zh) | 2014-04-30 |
RU2607657C2 (ru) | 2017-01-10 |
JP2017061489A (ja) | 2017-03-30 |
BR112014004635A2 (pt) | 2017-03-14 |
CA2844288A1 (en) | 2013-03-07 |
PL2750673T3 (pl) | 2018-11-30 |
NO2750673T3 (es) | 2018-01-06 |
DK2750673T3 (da) | 2017-11-20 |
BR112014004635B1 (pt) | 2022-09-13 |
RU2014111255A (ru) | 2015-10-10 |
PT2750673T (pt) | 2017-11-15 |
KR101933610B1 (ko) | 2018-12-28 |
JP6203364B2 (ja) | 2017-09-27 |
JP6035335B2 (ja) | 2016-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2646737T3 (es) | Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico | |
ES2543977T3 (es) | Sistema terapéutico transdérmico para la administración del principio activo buprenorfina | |
ES2536206T3 (es) | Parche medicinal | |
ES2502472T3 (es) | Composición adhesiva para su uso en un inmunosensor | |
CL2014001450A1 (es) | Forma de dosis de liberacion controlada solida que comprende un analgesico opioide dispersado en un material de matriz; metodo de preparacion; uso en el tratamiento del dolor. | |
ES2471951T3 (es) | Procedimiento y dispositivo para el estampado en caliente | |
ES2496092T3 (es) | El uso de amisulprida para tratar náuseas y vómitos posoperatorios | |
ES2529464T3 (es) | Lámina o cinta adhesiva sensible a la presión para aplicación cutánea y proceso para producir la misma | |
PE20151147A1 (es) | Sistema de liberacion transdermica | |
ES2513691T3 (es) | Preparación transdérmica | |
AR088232A1 (es) | Composiciones farmaceuticas | |
ES2486615A2 (es) | Formulación, resina o extruido para conformar una estructura celular aislante, polimérica y no aromática, artículo y material que se obtiene, recipiente conformado y proceso de obtención. | |
CL2012003281A1 (es) | Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica. | |
AR096521A1 (es) | Sistema de liberación transdérmico, uso, método de fabricación | |
CL2013000424A1 (es) | Forma de dosificacion farmaceutica resistente al rompimiento que comprende a) un ingrediente farmacologicamente activo, b) un polimero, c) un oxido de polialquileno, donde a) esta presente en una matriz de liberacion controlada que comprende b) y c). | |
CY1116638T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας | |
CL2009001556A1 (es) | Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol. | |
ES2529662T3 (es) | Parche adhesivo médico | |
ES2543957T3 (es) | Nueva composición farmacéutica para el tratamiento de infecciones fúngicas | |
CL2013000477A1 (es) | Formulacion farmaceutica oral de liberacion inmediata que comprende nalbufina o una sal de la misma, y al menos, un soporte de granulacion hidrofilo, un aglutinante hidrofilo y un lubricante, util para el tratamiento del dolor y la dependencia a los opioides. | |
AR082640A1 (es) | Un dispositivo para la administracion transdermal de compuestos alcalinos susceptibles a la degradacion en su forma no salificada | |
AR095672A1 (es) | Composiciones farmacéuticas que comprenden everolimus | |
AR070031A1 (es) | Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas | |
ES2617360T3 (es) | Estructura laminada para la visualización de información | |
AR089765A1 (es) | Un sistema para el suministro de un farmaco |